Page last updated: 2024-08-23

amikacin and moxalactam

amikacin has been researched along with moxalactam in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-199020 (76.92)18.7374
1990's2 (7.69)18.2507
2000's2 (7.69)29.6817
2010's2 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Girlich, D; Nordmann, P; Poirel, L1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Blaser, J1
Evagelopoulou, V; Giamarellou, H; Lelekis, M1
Blaser, J; Zinner, SH1
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP1
De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW1
Sabath, LD; Tack, KJ1
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR1
Angel Montañés, M; Apraiz, D; Gamazo, C; Urra, E1
De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH1
McNamara, BT; Meyer, RD; Pasiecznik, KA1
Barriere, SL; Pons, VG; Wilson, CB1
Berk, SL; Verghese, A1
Bauer, D; Spohr, M; Traub, WH1
Meyer, RD; Pasiecznik, K1
Holloway, WJ; Reinhardt, JF1
Baker, CJ; Faingezicht, I; Feldman, WE; Kaplan, SL; McCracken, GH; Mize, S; Schaad, U; Threlkeld, N1
Bustamante, CI; Drusano, GL; Standiford, HC; Tatem, BA1
Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR1
Mirrett, S; Reimer, LG; Reller, LB1
Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS1
Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH1
Bourquelot, P; Bouscary, D; Dreyfus, F; Paul, G; Picard, F; Tulliez, M; Varet, B1

Trials

4 trial(s) available for amikacin and moxalactam

ArticleYear
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation

1986
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    The American journal of medicine, 1982, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin

1982
Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation.
    JAMA, 1984, Sep-21, Volume: 252, Issue:11

    Topics: Amikacin; Ampicillin; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Infant, Newborn; Meningitis; Moxalactam; Prospective Studies; Radiography

1984
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:2

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin

1982

Other Studies

22 other study(ies) available for amikacin and moxalactam

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
    Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74

    Topics: Amikacin; Azlocillin; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus

1990
Enhanced in-vitro bactericidal activity of amikacin combined with latamoxef, cefotaxime and aztreonam against multi-resistant Enterobacter cloacae.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:4

    Topics: Amikacin; Aztreonam; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors

1989
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Drug Combinations; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins

1986
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin

1987
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
    Chemotherapy, 1985, Volume: 31, Issue:3

    Topics: Amikacin; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Salmonella; Serratia; Staphylococcus; Streptococcus; Tobramycin

1985
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Boletin de la Asociacion Medica de Puerto Rico, 1985, Volume: 77, Issue:6

    Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa

1985
[Comparison of the in vitro activity of amikacin, netilmicin, piperacillin and moxalactam against Acinetobacter calcoaceticus var. anitratum].
    Medicina clinica, 1985, Nov-16, Volume: 85, Issue:16

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin

1985
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa

1982
Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Neurosurgery, 1982, Volume: 10, Issue:6 Pt 1

    Topics: Amikacin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam

1982
Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
    The American journal of medicine, 1983, Volume: 74, Issue:6

    Topics: Agranulocytosis; Amikacin; Cephalosporins; Cephamycins; Drug Therapy, Combination; Humans; Infections; Kanamycin; Moxalactam; Penicillins; Ticarcillin

1983
Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.
    Chemotherapy, 1983, Volume: 29, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephamycins; Culture Media; DNA, Bacterial; Drug Resistance, Microbial; Moxalactam; Plasmids; Serratia marcescens

1983
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Diagnostic microbiology and infectious disease, 1983, Volume: 1, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1983
Serratia marcescens pyarthrosis and osteomyelitis.
    Southern medical journal, 1984, Volume: 77, Issue:8

    Topics: Adult; Amikacin; Amphetamine; Arthritis, Infectious; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Male; Moxalactam; Osteomyelitis; Serratia marcescens; Substance-Related Disorders; Suppuration

1984
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Imipenem; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins; Time Factors

1984
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
    Infection, 1980, Volume: 8 Suppl 3

    Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin

1980
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:3

    Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin

1980
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
    The American journal of medicine, 1984, Volume: 77, Issue:3

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections

1984
Hemophagocytic syndrome associated with Bacteroides fragilis infection in a patient with acute monoblastic leukemia.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2

    Topics: Amikacin; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Ceftazidime; Cytarabine; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Leukemia, Monocytic, Acute; Middle Aged; Moxalactam; Tonsillitis; Vancomycin

1996